 | • レポートコード：QYR9NV11072 • 出版社/出版日：QYResearch / 2019年11月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、組換えペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルカゴン、カルシトニン、その他に、用途別には、インスリン、ヒト成長ホルモン、血液製剤、その他にセグメント区分し、組換えペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換えペプチドの世界市場概要 ・組換えペプチドの製造コスト構成分析 ・組換えペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換えペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換えペプチドのセグメント分析（種類別） （グルカゴン、カルシトニン、その他） ・組換えペプチドのセグメント分析（用途別） （インスリン、ヒト成長ホルモン、血液製剤、その他） ・組換えペプチドの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Sandoz Pharma、Stada Arzneimittel、Amgen、Hospira、Actavis、Cipla Ltd.、Wockhardt Ltd.、Biocon Ltd.、） ・組換えペプチドの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Peptides market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Peptides in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Peptides manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Glucagon
Calcitonin
Other
Segment by Application
Insulin
Human Growth Hormone
Blood Products
Other
Table of Contents
Executive Summary
1 Industry Overview of Recombinant Peptides
1.1 Definition of Recombinant Peptides
1.2 Recombinant Peptides Segment by Type
1.2.1 Global Recombinant Peptides Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Glucagon
1.2.3 Calcitonin
1.2.4 Other
1.3 Recombinant Peptides Segment by Applications
1.3.1 Global Recombinant Peptides Consumption Comparison by Applications (2014-2025)
1.3.2 Insulin
1.3.3 Human Growth Hormone
1.3.4 Blood Products
1.3.5 Other
1.4 Global Recombinant Peptides Overall Market
1.4.1 Global Recombinant Peptides Revenue (2014-2025)
1.4.2 Global Recombinant Peptides Production (2014-2025)
1.4.3 North America Recombinant Peptides Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Peptides Status and Prospect (2014-2025)
1.4.5 China Recombinant Peptides Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Peptides Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Peptides Status and Prospect (2014-2025)
1.4.8 India Recombinant Peptides Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Peptides
2.3 Manufacturing Process Analysis of Recombinant Peptides
2.4 Industry Chain Structure of Recombinant Peptides
3 Development and Manufacturing Plants Analysis of Recombinant Peptides
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Peptides Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Peptides
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Recombinant Peptides Production and Capacity Analysis
4.2 Recombinant Peptides Revenue Analysis
4.3 Recombinant Peptides Price Analysis
4.4 Market Concentration Degree
5 Recombinant Peptides Regional Market Analysis
5.1 Recombinant Peptides Production by Regions
5.1.1 Global Recombinant Peptides Production by Regions
5.1.2 Global Recombinant Peptides Revenue by Regions
5.2 Recombinant Peptides Consumption by Regions
5.3 North America Recombinant Peptides Market Analysis
5.3.1 North America Recombinant Peptides Production
5.3.2 North America Recombinant Peptides Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Peptides Import and Export
5.4 Europe Recombinant Peptides Market Analysis
5.4.1 Europe Recombinant Peptides Production
5.4.2 Europe Recombinant Peptides Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Peptides Import and Export
5.5 China Recombinant Peptides Market Analysis
5.5.1 China Recombinant Peptides Production
5.5.2 China Recombinant Peptides Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Peptides Import and Export
5.6 Japan Recombinant Peptides Market Analysis
5.6.1 Japan Recombinant Peptides Production
5.6.2 Japan Recombinant Peptides Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Peptides Import and Export
5.7 Southeast Asia Recombinant Peptides Market Analysis
5.7.1 Southeast Asia Recombinant Peptides Production
5.7.2 Southeast Asia Recombinant Peptides Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Peptides Import and Export
5.8 India Recombinant Peptides Market Analysis
5.8.1 India Recombinant Peptides Production
5.8.2 India Recombinant Peptides Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Peptides Import and Export
6 Recombinant Peptides Segment Market Analysis (by Type)
6.1 Global Recombinant Peptides Production by Type
6.2 Global Recombinant Peptides Revenue by Type
6.3 Recombinant Peptides Price by Type
7 Recombinant Peptides Segment Market Analysis (by Application)
7.1 Global Recombinant Peptides Consumption by Application
7.2 Global Recombinant Peptides Consumption Market Share by Application (2014-2019)
8 Recombinant Peptides Major Manufacturers Analysis
8.1 Sandoz Pharma
8.1.1 Sandoz Pharma Recombinant Peptides Production Sites and Area Served
8.1.2 Sandoz Pharma Product Introduction, Application and Specification
8.1.3 Sandoz Pharma Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Stada Arzneimittel
8.2.1 Stada Arzneimittel Recombinant Peptides Production Sites and Area Served
8.2.2 Stada Arzneimittel Product Introduction, Application and Specification
8.2.3 Stada Arzneimittel Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amgen
8.3.1 Amgen Recombinant Peptides Production Sites and Area Served
8.3.2 Amgen Product Introduction, Application and Specification
8.3.3 Amgen Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hospira
8.4.1 Hospira Recombinant Peptides Production Sites and Area Served
8.4.2 Hospira Product Introduction, Application and Specification
8.4.3 Hospira Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Actavis
8.5.1 Actavis Recombinant Peptides Production Sites and Area Served
8.5.2 Actavis Product Introduction, Application and Specification
8.5.3 Actavis Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cipla Ltd.
8.6.1 Cipla Ltd. Recombinant Peptides Production Sites and Area Served
8.6.2 Cipla Ltd. Product Introduction, Application and Specification
8.6.3 Cipla Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Wockhardt Ltd.
8.7.1 Wockhardt Ltd. Recombinant Peptides Production Sites and Area Served
8.7.2 Wockhardt Ltd. Product Introduction, Application and Specification
8.7.3 Wockhardt Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biocon Ltd.
8.8.1 Biocon Ltd. Recombinant Peptides Production Sites and Area Served
8.8.2 Biocon Ltd. Product Introduction, Application and Specification
8.8.3 Biocon Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Recombinant Peptides Market
9.1 Global Recombinant Peptides Market Trend Analysis
9.1.1 Global Recombinant Peptides Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Peptides Regional Market Trend
9.2.1 North America Recombinant Peptides Forecast 2019-2025
9.2.2 Europe Recombinant Peptides Forecast 2019-2025
9.2.3 China Recombinant Peptides Forecast 2019-2025
9.2.4 Japan Recombinant Peptides Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Peptides Forecast 2019-2025
9.2.6 India Recombinant Peptides Forecast 2019-2025
9.3 Recombinant Peptides Market Trend (Product Type)
9.4 Recombinant Peptides Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Peptides Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Recombinant Peptides
Table Global Recombinant Peptides Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Peptides Production Market Share by Types in 2018
Figure Glucagon Product Picture
Figure Calcitonin Product Picture
Figure Other Product Picture
Table Global Recombinant Peptides Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Recombinant Peptides Consumption Market Share by Applications in 2018
Figure Insulin
Figure Human Growth Hormone
Figure Blood Products
Figure Other
Figure Global Recombinant Peptides Revenue (Million USD) (2014-2025)
Figure Global Recombinant Peptides Production (K MT) (2014-2025)
Figure North America Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure China Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure India Recombinant Peptides Market Size (Million USD) (2014-2025)
Table Recombinant Peptides Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Peptides in 2018
Figure Manufacturing Process Analysis of Recombinant Peptides
Figure Industry Chain Structure of Recombinant Peptides
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Peptides Manufacturing Plants Distribution
Table Recombinant Peptides Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Peptides Capacity (K MT) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Production (K MT) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Peptides Production Share by Manufacturers in 2018
Table Recombinant Peptides Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Peptides Revenue Share by Manufacturers in 2018
Table Recombinant Peptides Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Peptides Production by Regions 2014-2019 (K MT)
Table Global Recombinant Peptides Production Market Share by Regions 2014-2019
Figure Global Recombinant Peptides Production Market Share by Regions in 2018
Table Global Recombinant Peptides Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Peptides Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Peptides Revenue Market Share by Regions in 2018
Table Global Recombinant Peptides Consumption by Regions 2014-2019 (K MT)
Table Global Recombinant Peptides Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure North America Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Europe Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Europe Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure China Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure China Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Japan Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Japan Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Southeast Asia Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure India Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure India Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Global Consumption Recombinant Peptides Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Peptides Market Share by Application (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Sites and Area Served
Table Sandoz Pharma Recombinant Peptides Product Introduction, Application and Specification
Table Sandoz Pharma Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Growth Rate (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Market Share (2014-2019)
Figure Sandoz Pharma Recombinant Peptides Revenue Market Share (2014-2019)
Table Sandoz Pharma Recombinant Peptides Main Business and Markets Served
Table Stada Arzneimittel Recombinant Peptides Production Sites and Area Served
Table Stada Arzneimittel Recombinant Peptides Product Introduction, Application and Specification
Table Stada Arzneimittel Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Production Growth Rate (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Production Market Share (2014-2019)
Figure Stada Arzneimittel Recombinant Peptides Revenue Market Share (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Main Business and Markets Served
Table Amgen Recombinant Peptides Production Sites and Area Served
Table Amgen Recombinant Peptides Product Introduction, Application and Specification
Table Amgen Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Recombinant Peptides Production Growth Rate (2014-2019)
Table Amgen Recombinant Peptides Production Market Share (2014-2019)
Figure Amgen Recombinant Peptides Revenue Market Share (2014-2019)
Table Amgen Recombinant Peptides Main Business and Markets Served
Table Hospira Recombinant Peptides Production Sites and Area Served
Table Hospira Recombinant Peptides Product Introduction, Application and Specification
Table Hospira Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Hospira Recombinant Peptides Production Growth Rate (2014-2019)
Table Hospira Recombinant Peptides Production Market Share (2014-2019)
Figure Hospira Recombinant Peptides Revenue Market Share (2014-2019)
Table Hospira Recombinant Peptides Main Business and Markets Served
Table Actavis Recombinant Peptides Production Sites and Area Served
Table Actavis Recombinant Peptides Product Introduction, Application and Specification
Table Actavis Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Actavis Recombinant Peptides Production Growth Rate (2014-2019)
Table Actavis Recombinant Peptides Production Market Share (2014-2019)
Figure Actavis Recombinant Peptides Revenue Market Share (2014-2019)
Table Actavis Recombinant Peptides Main Business and Markets Served
Table Cipla Ltd. Recombinant Peptides Production Sites and Area Served
Table Cipla Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Cipla Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Cipla Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Cipla Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Cipla Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Cipla Ltd. Recombinant Peptides Main Business and Markets Served
Table Wockhardt Ltd. Recombinant Peptides Production Sites and Area Served
Table Wockhardt Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Wockhardt Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Wockhardt Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Main Business and Markets Served
Table Biocon Ltd. Recombinant Peptides Production Sites and Area Served
Table Biocon Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Biocon Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Biocon Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Biocon Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Biocon Ltd. Recombinant Peptides Main Business and Markets Served
Figure Global Recombinant Peptides Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Recombinant Peptides Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Peptides Sales Price (USD/MT) Forecast 2019-2025
Figure North America Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Recombinant Peptides by Type (2019-2025)
Table Global Consumption (K MT) of Recombinant Peptides by Application (2019-2025)
Table Recombinant Peptides Distributors List
Table Recombinant Peptides Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
組換えペプチドのグローバル市場調査 2019年 The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, th…- 組み換えヒトエンドスタチンのグローバル市場調査 2019年 The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global…
- 組み換えヒトエンドスタチンのグローバル市場調査 2019年 The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global…
- 抗菌ペプチドのグローバル市場調査 2019年 The global Antimicrobial Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antimicrobial Peptides volume and value at global level, regional level and company level. From a global perspective…
- 世界の組換えヒトインスリン産業調査2019-2025 Insulin is a well-characterized peptide that can be produced byrecombinant DNA technology for human therapeutic use.In 2018, the global Recombinant Human Insulin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been …